NCT03603782 is a NA clinical trial of 2.5% protein in Healthy, sponsored by Société des Produits Nestlé (SPN).

Who is sponsoring NCT03603782?

NCT03603782 is sponsored by Société des Produits Nestlé (SPN).

What drugs are being tested in NCT03603782?

Interventions in NCT03603782: 2.5% protein, protein 5%, protein 10%, protein 15%, A2: Peptamen 1.5 Vanilla without Breakfast, B2: only breakfast (no product), C2: 5% protein with breakfast, D2: 5% protein 30 min before breakfast.

Is NCT03603782 still recruiting?

NCT03603782 is currently completed. Last updated 19 September 2024.

Last reviewed 2024-09-19 · How we verify

NCT03603782

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ketone Plasma Kinetics After Oral Intake Of Different MCT

Completed NA Last updated 19 September 2024

What this trial tests

NA trial testing 2.5% protein in Healthy in 20 participants. Completed in 31 May 2024.

Timeline

4 June 2018

Primary endpoint
31 May 2024

31 May 2024

Quick facts

Lead sponsor	Société des Produits Nestlé (SPN)
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	basic science
Enrollment	20
Start date	4 June 2018
Primary completion	31 May 2024
Estimated completion	31 May 2024
Sites	1 location across Switzerland

Drugs / interventions tested

2.5% protein
protein 5%
protein 10%
protein 15%
A2: Peptamen 1.5 Vanilla without Breakfast
B2: only breakfast (no product)
C2: 5% protein with breakfast
D2: 5% protein 30 min before breakfast

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Société des Produits Nestlé (SPN) — full company profile →

Who can join

Adults 18 to 50, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research project is aimed at identifying the MCT formulation matrixes that provide the highest ketoindex values and extended half-life, as well as to provide an initial evaluation of the GI tolerability of the various formula. For comparison, ketones salts and esters (food grade) will be also evaluated.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Metabolism of Exogenous D-Beta-Hydroxybutyrate, an Energy Substrate Avidly Consumed by the Heart and Kidney.
Cuenoud B, Hartweg M, Godin JP, Croteau E, et al · · 2020 · cited 61× · PMID 32140471 · DOI 10.3389/fnut.2020.00013
Long-term use of investigational β-Hydroxybutyrate salts in children with multiple acyl-CoA dehydrogenase or pyruvate dehydrogenase deficiency.
Morris AAM, Cuenoud B, Delerive P, Mundy H, et al · · 2024 · cited 2× · PMID 38983107 · DOI 10.1016/j.ymgmr.2024.101104

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other Société des Produits Nestlé (SPN) trials

Trials by the same sponsor.

NCT07312201 — Oral Nutritional Supplementation in Children With Growth Concerns · NA · not yet recruiting
NCT07378111 — Vegetarian Tube Feed Study · NA · not yet recruiting
NCT07439718 — The Effects of an Oral Nutritional Intervention on the Small Intestine Microbiome · NA · recruiting
NCT07341464 — Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends · NA · recruiting
NCT07127198 — Tolerance and Appetite Reduction of a Nutritional Solution With Intragastric Gelation Properties · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03603782 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Société des Produits Nestlé (SPN)
Last refreshed: 19 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03603782.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing